Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men

Charles R. Rogers, Michael J. Rovito, Musse Hussein, Ogechi Jessica Obidike, Rebekah J Pratt, Mark Alexander, Jerica M Berge, Marc Dall'Era, Jeffrey W. Nix, Christopher A Warlick

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: Black men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted. Methods: A community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men's attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017. Results: Identified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent. Conclusions: Disparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research. Supplement information: This article is part of a supplement entitled African American Men's Health: Research, Practice, and Policy Implications, which is sponsored by the National Institutes of Health.

Original languageEnglish (US)
Pages (from-to)S103-S111
JournalAmerican journal of preventive medicine
Volume55
Issue number5
DOIs
StatePublished - Nov 1 2018

Fingerprint

Prostatic Neoplasms
Research
Delivery of Health Care
Personal Health Records
Health Literacy
Men's Health
Confusion
Validation Studies
National Institutes of Health (U.S.)
Prostate-Specific Antigen
Focus Groups
Health Education
Terminology
African Americans
Organizations
Education

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural

Cite this

Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men. / Rogers, Charles R.; Rovito, Michael J.; Hussein, Musse; Obidike, Ogechi Jessica; Pratt, Rebekah J; Alexander, Mark; Berge, Jerica M; Dall'Era, Marc; Nix, Jeffrey W.; Warlick, Christopher A.

In: American journal of preventive medicine, Vol. 55, No. 5, 01.11.2018, p. S103-S111.

Research output: Contribution to journalArticle

Rogers, Charles R. ; Rovito, Michael J. ; Hussein, Musse ; Obidike, Ogechi Jessica ; Pratt, Rebekah J ; Alexander, Mark ; Berge, Jerica M ; Dall'Era, Marc ; Nix, Jeffrey W. ; Warlick, Christopher A. / Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men. In: American journal of preventive medicine. 2018 ; Vol. 55, No. 5. pp. S103-S111.
@article{1e46e12ab21b46118fdce31de71fba15,
title = "Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men",
abstract = "Introduction: Black men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted. Methods: A community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men's attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017. Results: Identified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent. Conclusions: Disparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research. Supplement information: This article is part of a supplement entitled African American Men's Health: Research, Practice, and Policy Implications, which is sponsored by the National Institutes of Health.",
author = "Rogers, {Charles R.} and Rovito, {Michael J.} and Musse Hussein and Obidike, {Ogechi Jessica} and Pratt, {Rebekah J} and Mark Alexander and Berge, {Jerica M} and Marc Dall'Era and Nix, {Jeffrey W.} and Warlick, {Christopher A}",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.amepre.2018.05.028",
language = "English (US)",
volume = "55",
pages = "S103--S111",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men

AU - Rogers, Charles R.

AU - Rovito, Michael J.

AU - Hussein, Musse

AU - Obidike, Ogechi Jessica

AU - Pratt, Rebekah J

AU - Alexander, Mark

AU - Berge, Jerica M

AU - Dall'Era, Marc

AU - Nix, Jeffrey W.

AU - Warlick, Christopher A

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Introduction: Black men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted. Methods: A community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men's attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017. Results: Identified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent. Conclusions: Disparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research. Supplement information: This article is part of a supplement entitled African American Men's Health: Research, Practice, and Policy Implications, which is sponsored by the National Institutes of Health.

AB - Introduction: Black men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted. Methods: A community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men's attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017. Results: Identified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent. Conclusions: Disparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research. Supplement information: This article is part of a supplement entitled African American Men's Health: Research, Practice, and Policy Implications, which is sponsored by the National Institutes of Health.

UR - http://www.scopus.com/inward/record.url?scp=85055652448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055652448&partnerID=8YFLogxK

U2 - 10.1016/j.amepre.2018.05.028

DO - 10.1016/j.amepre.2018.05.028

M3 - Article

VL - 55

SP - S103-S111

JO - American Journal of Preventive Medicine

JF - American Journal of Preventive Medicine

SN - 0749-3797

IS - 5

ER -